11:41AM ET 2/08/2023 MT NewswiresFortress Biotech (FBIO) said Wednesday that it has agreed to sell 16.6 million common shares at $0.835 apiece in a registered direct offering to raise...
11:03AM ET 12/14/2022 MT NewswiresFortress Biotech (FBIO) subsidiary Urica Therapeutics said Wednesday it has expanded its gout drug development license agreement with Fuji Yakuhin to...
4:38PM ET 11/14/2022 MT NewswiresFortress Biotech (FBIO) reported Monday a Q3 non-GAAP loss of $0.08 per share, compared with earnings of $0.60 per share a year earlier. One analyst...